Entheon announces a new partnership to advance its psychedelic drug R&D.
Pure Extracts Corp
Company Brief
Pure Extracts uses CO2 extraction technology to derive full spectrum oil from cannabis biomass. We are an emerging leader in the extraction space offering only the purest quality oil.
Highlights
Related Articles
CYBIN Announces Upsize to Previously Announced Bought Deal Offering
Cybin's bought deal financing has been upsized to CAD$30 million.
TSI EDITOR |
2021-01-19
Low Tide For Psychedelic Stocks With Media, Investors Distracted
The U.S. election has become a major political circus. With investors distracted and the media focused elsewhere, psychedelic stocks are temporarily at low tide.
TSI EDITOR |
2021-01-19
Cybin Announces CDN$20 Million Bought Deal Offering
Cybin Corp announces a CAD$20 million financing at a unit price of CAD$2.25.
TSI EDITOR |
2021-01-18
Entheon Biomedical Corp. Announces Acquisition of HaluGen Life Sciences Inc.
Entheon acquires a genetic screening company to identify genetic markers that affect reactions to hallucinogenic drugs.
TSI EDITOR |
2021-01-14
Mydecine Innovations Group Upsizes Previously Announced Bought Deal
Mydecine's bought-deal financing is upsized by 50% to CAD $15 million.
TSI EDITOR |
2021-01-14
Latest Stories
NEW BULL MARKET ALERT
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now